X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Adapting To The Changing Virus By Enhancing Vaccine Immunity

    UK Boosts Life Sciences Sector With £650 Million Funding

    UK Boosts Life Sciences Sector With £650 Million Funding

    Indian Pharma Business May Increase 8-11%, Predicts Alkem

    Chinese Market Regulator Fines Two Monopolistic Pharma Firms

    Enhancing Patient Care In The UK Through Recognition Routes

    Enhancing Patient Care In The UK Through Recognition Routes

    Battling Global Medicine Shortages With EMA Recommendations

    Genomics Market Growth In India To Accelerate Affordability

    EMA Reviews Hydroxyprogesterone Caproate For Safety Concerns

    WHO Utilizes Pathogen Genomics For Global Disease Protection

    Concerns Rise Over Shortage of Medical Products In The USA

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Adapting To The Changing Virus By Enhancing Vaccine Immunity

    UK Boosts Life Sciences Sector With £650 Million Funding

    UK Boosts Life Sciences Sector With £650 Million Funding

    Indian Pharma Business May Increase 8-11%, Predicts Alkem

    Chinese Market Regulator Fines Two Monopolistic Pharma Firms

    Enhancing Patient Care In The UK Through Recognition Routes

    Enhancing Patient Care In The UK Through Recognition Routes

    Battling Global Medicine Shortages With EMA Recommendations

    Genomics Market Growth In India To Accelerate Affordability

    EMA Reviews Hydroxyprogesterone Caproate For Safety Concerns

    WHO Utilizes Pathogen Genomics For Global Disease Protection

    Concerns Rise Over Shortage of Medical Products In The USA

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Adapting To The Changing Virus By Enhancing Vaccine Immunity

Content Team by Content Team
3rd June 2023
in News, Research & Development

A report has been published by international regulators that highlights the outcomes of the discussion they had pertaining to COVID-19 vaccines, as well as the need for and the strategy so as to update the composition based on evidence on the SARS-CoV-2 variants of the coronavirus and the lessons that have been learned from the prior vaccine updates.

The workshop was organised under the umbrella of the International Coalition of Medicines Regulatory Authorities and co-chaired by the US FDA as well as the European Medicines Agency.

It is well to be noted that the vaccines that happen to be authorised continue to be effective when it comes to the prevention of hospitalisation, severe illness, or even death because of COVID-19. That said, the protection against the infection fades away with time and as new variants start to emerge. According to preliminary data, COVID-19 strains that are well adapted to the present floating strains enhance immunity to recently emerging variants like XBB descendant lineages.

The participants discussed the scientifically available evidence on seroprevalence, which happens to be the number of people in a population who go on to test positive for a specific disease and is based on blood serum measurements, epidemiology, the performance of the vaccine, and also the major regulatory considerations that happen to be related to the adaptation of new COVID-19 vaccines or even the authorised ones against the emerging variants.

An agreement is there on the fact that the vaccine formulations for the upcoming winter season within the Northern Hemisphere must go on to include just one virus strain and be based on the XBB family of Omicron-related subvariants.

International regulators also went on to highlight the fact that such monovalent vaccines can be used for both boosters and primary vaccinations (the latter only in the case of children below 4-5 years). The regulators also noted that only the data on manufacturing as well as vaccine quality and lab shall be required when it comes to approval for strain changes for the COVID-19 vaccines that are authorised, provided that post-approval data when it comes to the vaccine’s quality, immunogenicity, effectiveness, and safety is collected.

Meeting based on knowledge and experience which were gained from a series of ICMRA workshops pertaining to COVID-19 vaccine development as well as virus variants in the past three years. The participants of the meeting included experts from the WHO and representatives of international regulators.

Previous Post

Emerging Trends Reshaping The Pharmaceutical Supply Chain

Related Posts

IPR Data Management

Emerging Trends Reshaping The Pharmaceutical Supply Chain

31st May 2023
UK Boosts Life Sciences Sector With £650 Million Funding
News

UK Boosts Life Sciences Sector With £650 Million Funding

30th May 2023
WHO And Korea Sign MoU For Biomanufacturing Training Hub
Facilities & Operation

WHO And Korea Sign MoU For Biomanufacturing Training Hub

30th May 2023
Indian Pharma Business May Increase 8-11%, Predicts Alkem
FDA Approvals

Chinese Market Regulator Fines Two Monopolistic Pharma Firms

30th May 2023
Enhancing Patient Care In The UK Through Recognition Routes
FDA Approvals

Enhancing Patient Care In The UK Through Recognition Routes

29th May 2023
Drug Development

Battling Global Medicine Shortages With EMA Recommendations

27th May 2023

Latest News

News

Adapting To The Changing Virus By Enhancing Vaccine Immunity

3rd June 2023
IPR Data Management

Emerging Trends Reshaping The Pharmaceutical Supply Chain

31st May 2023
UK Boosts Life Sciences Sector With £650 Million Funding
News

UK Boosts Life Sciences Sector With £650 Million Funding

30th May 2023
WHO And Korea Sign MoU For Biomanufacturing Training Hub
Facilities & Operation

WHO And Korea Sign MoU For Biomanufacturing Training Hub

30th May 2023
Indian Pharma Business May Increase 8-11%, Predicts Alkem
FDA Approvals

Chinese Market Regulator Fines Two Monopolistic Pharma Firms

30th May 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In